首页|阿那白滞素在炎症性皮肤病中的临床应用

阿那白滞素在炎症性皮肤病中的临床应用

扫码查看
白细胞介素-1(IL-1)是一种重要的细胞因子,参与许多炎症性疾病的发病.IL-1抑制剂成为治疗这类疾病的有效方法.阿那白滞素(anakinra)是最早上市且应用最多的IL-1抑制剂,在一些炎症性皮肤病中显示出良好的疗效.本文主要就阿那白滞素在成人Still病、Schnitzler综合征、化脓性汗腺炎、脓疱型银屑病、白塞病、坏疽性脓皮病中的临床应用进行综述.
Application of anakinra in inflammatory dermatoses
Interleukin 1(IL-1)is an important cytokine,which is involved in the development of many inflammatory diseases.IL-1 inhibitors have become an effective approach in the treatment of these diseases.Anakinra is the first and the most widely used IL-1 inhibitor on the market.Studies have shown satisfactory efficacy in the treatment of some inflammatory dermatoses.This re-view mainly summarizes applications of anakinra in adult-onset Still's disease,Schnitzler syn-drome,hidradenitis suppurativa,pustular psoriasis,Bechet disease and pyoderma gangrenosum.

IL-1IL-1 inhibitorsanakinrainflammatory skin diseases

游晓媚、古甘霖、江燕云、王亮春

展开 >

中山大学孙逸仙纪念医院,广东 广州 510120

IL-1 IL-1抑制剂 阿那白滞素 炎症性皮肤病

2024

皮肤性病诊疗学杂志
广东省皮肤性病防治中心

皮肤性病诊疗学杂志

影响因子:0.666
ISSN:1674-8468
年,卷(期):2024.31(1)
  • 1